Search
for
Sort by
Research 181–210 of 1000+
- EFFECTS OF HORMONAL THERAPY IN TRANSGENDERS
- Androgenisierung
- Endocrine care of transpeople part I. A review of cross-sex hormonal treatments, outcomes and adverse effects in transmen
- Testosterone therapy for transgender men
- Salvage Therapy for Prostate Cancer: AUA/ASTRO/SUO Guideline Part II: Treatment Delivery for Non-metastatic Biochemical Recurrence After Primary Radical Prostatectomy
- Diseases of the Canine Prostate Gland
- Ketoconazole use in the treatment of ovarian hyperandrogenism
- Rationale and design of the GLADE study: a randomized, multicenter, double-blind, placebo-controlled trial evaluating the safety and efficacy of gestrinone subdermal bioabsorbable pellet in endometriosis-related pelvic pain
- Treatment options for polycystic ovary syndrome
- Phase 2, double-blind, randomized, placebo-controlled study of the safety and efficacy of elagolix in women with polycystic ovary syndrome
- Unusual presentation with polymenorrhagia and markedly high 17-hydroxy progesterone levels in a lady with Non-Classic Congenital Adrenal Hyperplasia.
- Role of OCT4 in the Regulation of FSH-Induced Granulosa Cells Growth in Female Mice
- Postmenopausal hyperandrogenism
- Menopausal Androgen Excess - Associated Cardio-Metabolic Risk: Clues for Ovarian Leydig Cell Tumour (Case Report and Mini-Review of Literature)
- Managing Dermatologic Effects of Gender-Affirming Therapy in Transgender Adolescents
- Characterizing Dermatological Conditions in the Transgender Population: A Cross-Sectional Study
- Dermatological care of gender‐diverse patients in Australia
- An update of polycystic ovary syndrome: causes and therapeutics options
- Impact of Reducing Obesity in PCOS: Methods and Treatment Outcomes
- Research gaps in medical treatment of transgender/nonbinary people
- Intracrine androgen biosynthesis, metabolism and action revisited
- Impact of estrogens in males and androgens in females
- Resistance to the Insulin and Elevated Level of Androgen: A Major Cause of Polycystic Ovary Syndrome
- Impaired Prolactin-Lowering Effects of Metformin in Women with Polycystic Ovary Syndrome
- Recent advances in neuropeptide-related omics and gene editing: Spotlight on NPY and somatostatin and their roles in growth and food intake of fish
- Clomiphene Citrate as Nanomedicine Assistance in Ovulatory Disorders and Its Hyphenated Techniques
- Society for Endocrinology Clinical Practice Guideline for the Evaluation of Androgen Excess in Women
- Recommendations from the 2023 International Evidence-based Guideline for the Assessment and Management of Polycystic Ovary Syndrome
- Nitric Oxide: Physiological Functions, Delivery, and Biomedical Applications
- Update on Melasma—Part I: Pathogenesis